These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6108046)

  • 1. Microscopic evidence of lymphogenic absorption of oil in humans receiving neuroleptic oily depot preparations intramuscularly.
    Svendsen O; Dencker SJ; Fog R; Gravem AO; Kristjansen P
    Acta Pharmacol Toxicol (Copenh); 1980 Aug; 47(2):157-8. PubMed ID: 6108046
    [No Abstract]   [Full Text] [Related]  

  • 2. Local muscle damage and oily vehicles: a study on local reactions in rabbits after intramuscular injection of neuroleptic drugs in aqueous or oily vehicles.
    Svendsen O
    Acta Pharmacol Toxicol (Copenh); 1983 Apr; 52(4):298-304. PubMed ID: 6135293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the fate of vegetable oit after intramuscular injection into experimental animals.
    Svendsen O; Aaes-Jørgensen T
    Acta Pharmacol Toxicol (Copenh); 1979 Nov; 45(5):352-78. PubMed ID: 539434
    [No Abstract]   [Full Text] [Related]  

  • 4. Postbasic nursing procedures. 1. Giving depot neuroleptic drugs.
    Nurs Mirror; 1982 Apr; 154(16):42-3. PubMed ID: 6123107
    [No Abstract]   [Full Text] [Related]  

  • 5. Dosaging patterns in schizophrenia with depot, oral and combined neuroleptic therapy.
    Remington GJ; Prendergast P; Bezchlibnyk-Butler KZ
    Can J Psychiatry; 1993 Apr; 38(3):159-61. PubMed ID: 8098988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The significance of vehicle oil metabolism in the absorption process of lipid-soluble compounds.
    Noguchi T; Taniguchi K; Muranishi S; Sezaki H
    Chem Pharm Bull (Tokyo); 1977 Mar; 25(3):434-40. PubMed ID: 872276
    [No Abstract]   [Full Text] [Related]  

  • 7. Intramuscular preparations of antipsychotics: uses and relevance in clinical practice.
    Altamura AC; Sassella F; Santini A; Montresor C; Fumagalli S; Mundo E
    Drugs; 2003; 63(5):493-512. PubMed ID: 12600227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic implications of different oil vehicles used in depot neuroleptic treatment.
    Knudsen P; Hansen LB; Larsen NE
    Acta Psychiatr Scand Suppl; 1985; 322():7-10. PubMed ID: 3865501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous magnetic resonance imaging and pharmacokinetic analysis of intramuscular depots.
    Probst M; Kühn JP; Scheuch E; Seidlitz A; Hadlich S; Evert K; Oswald S; Siegmund W; Weitschies W
    J Control Release; 2016 Apr; 227():1-12. PubMed ID: 26899995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [EFFECT OF DOSAGE FORMS ON THE RESORPTION OF DRUGS].
    FINHOLT P
    Sven Farm Tidskr; 1964 May; 68():345-51 CONCL. PubMed ID: 14146538
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on the mechanism of absorption of depot neuroleptics: fluphenazine decanoate in sesame oil.
    Luo JP; Hubbard JW; Midha KK
    Pharm Res; 1997 Aug; 14(8):1079-84. PubMed ID: 9279892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the absorption of practically water-insoluble drugs following injection. IV. An approach for predicting relative intramuscular absorption rates of a drug in oily solution, aqueous suspension and aqueous surfactant solution in rats.
    Hirano K; Yamada H
    Chem Pharm Bull (Tokyo); 1981 May; 29(5):1410-5. PubMed ID: 7296708
    [No Abstract]   [Full Text] [Related]  

  • 13. [Fatal fat embolism following self injection of salad oil].
    Schneider V; Klug E; Helwing HP; Bartsch G
    Z Rechtsmed; 1971; 69(3):197-209. PubMed ID: 5153055
    [No Abstract]   [Full Text] [Related]  

  • 14. Abscesses following prolonged intramuscular administration of perphenazine enantate.
    Starmark JE; Forsman A; Wahlström
    Acta Psychiatr Scand; 1980 Aug; 62(2):154-7. PubMed ID: 6110312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is depot medication safe in the setting of myopathy?
    Price JR; Bastiampillai T; Dhillon RS
    Aust N Z J Psychiatry; 2009 Aug; 43(8):781-3. PubMed ID: 19629801
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug levels after withdrawal of long-term depot neuroleptics.
    Amdisen A; Thomsen NJ
    Lancet; 1981 Jun; 1(8235):1425. PubMed ID: 6113382
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effects and side effects of depot neuroleptics as perceived by patients].
    Trenckmann U
    Psychiatr Prax; 1990 Sep; 17(5):184-7. PubMed ID: 1980015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Facialis palsy attributable to depot antipsychotic therapy.
    Licina M; Tavcar R
    Can J Psychiatry; 2003 Nov; 48(10):712-3. PubMed ID: 14674060
    [No Abstract]   [Full Text] [Related]  

  • 19. A comparative study of depot injection techniques.
    Quartermaine S; Taylor R
    Nurs Times; 1995 Jul 26-Aug 1; 91(30):36-9. PubMed ID: 7644369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Technics for intramuscular injections of delayed-action neuroleptics].
    Bélanger-Annable MC
    Infirm Can; 1985 Sep; 27(8):26-9. PubMed ID: 2863219
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.